tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
XOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
PremiumRatingsXOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
2M ago
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
Premium
The Fly
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
2M ago
Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
Premium
Ratings
Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
2M ago
Buy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
PremiumRatingsBuy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
2M ago
Xoma price target lowered to $97 from $104 at H.C. Wainwright
Premium
The Fly
Xoma price target lowered to $97 from $104 at H.C. Wainwright
2M ago
Xoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
Premium
Ratings
Xoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
2M ago
Xoma Completes Acquisition of Mural Oncology
PremiumCompany AnnouncementsXoma Completes Acquisition of Mural Oncology
3M ago
Xoma announces closing of transaction to acquire Mural Oncology
Premium
The Fly
Xoma announces closing of transaction to acquire Mural Oncology
3M ago
Mural Oncology announces effectiveness of scheme of arrangement
Premium
The Fly
Mural Oncology announces effectiveness of scheme of arrangement
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100